What is the catalog number for ARHGEF1 Rabbit Polyclonal Antibody?

The catalog number for ARHGEF1 Rabbit Polyclonal Antibody is orb381047.

What sizes are available for ARHGEF1 Rabbit Polyclonal Antibody?

ARHGEF1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is ARHGEF1 Rabbit Polyclonal Antibody in stock?

ARHGEF1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

ARHGEF1 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Rho guanine nucleotide exchange factor 1; 115 kDa guanine nucleotide exchange factor; p115-RhoGEF; p115RhoGEF; Sub1.5; ARHGEF1

UniProt

Q92888

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the N-terminus of human ARHGEF1, different from the related mouse and rat sequences by one amino acid.

Target

Rho guanine nucleotide exchange factor 1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Rat Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Mouse, Rat, Human Immunocytochemistry/Immunofluorescence, 2μg/ml, Human Flow Cytometry (Fixed), 1-3μg/1x10^6 cells, Human

Form

Lyophilized

Molecular Weight

120 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, ICC, IF, IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.